A Parkinson's Disease programme at Stem Plus in Sofia is €3,000–€8,000, versus roughly €7,350–€27,600 in Saudi Arabia. About 5.2h from Riyadh, inside the EU, visa-free.
If you are researching Parkinson's Disease treatment from Saudi Arabia, the obstacle is usually access or cost: standard options have plateaued, and regenerative therapy at home runs to €7,350–€27,600. Stem Plus offers the same European GMP standard for a fraction of that — and an easy, mostly visa-free trip.
Parkinson's disease results from progressive loss of dopamine-producing neurons in the substantia nigra. Stem-cell research pursues two complementary routes: neurogenic cells differentiated toward dopamine neurons are studied to replace lost cells and restore dopamine signalling, while placental mesenchymal stem cells are explored for neuroprotection — slowing degeneration through anti-inflammatory and growth-factor secretion. Preclinical evidence suggests dopamine-releasing cells can reinnervate the striatum and that trophic factors may delay neuronal death. Key challenges are achieving cell survival, integration and functional restoration in a degenerating brain. Most trials are early-phase, with modest motor changes reported. It is delivered under a physician-led protocol and designed to complement your existing care.
| Saudi Arabia (home) | Stem Plus · EU | |
|---|---|---|
| Parkinson's Disease treatment | €7,350–€27,600 | €3,000–€8,000 |
| Regulation | varies | EU · GMP |
| Flight to Sofia | 5.2h from Riyadh | — |
This note is general information for planning, not legal or medical advice. Confirm entry rules for your nationality before booking.
Cost ranges are indicative market figures for planning, not quotes.
Médecine régénérative certifiée GMP au cœur de l'UE — à partir de 3 000–8 000 €, une fraction des prix américains ou allemands. Protocoles personnalisés pour patients de plus de 50 pays.
Évaluation médicale gratuite